Royal Bank of Canada’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-58
| Closed | – | – | 8006 |
|
|
2023
Q1 | $0 | Buy |
58
+18
| +45% | +$53 | ﹤0.01% | 7857 |
|
|
2022
Q4 | $0 | Sell |
40
-34
| -46% | -$145 | ﹤0.01% | 8109 |
|
|
2022
Q3 | $0 | Buy |
74
+12
| +19% | +$85 | ﹤0.01% | 8169 |
|
|
2022
Q2 | $0 | Sell |
62
-199
| -76% | -$1.86K | ﹤0.01% | 8094 |
|
|
2022
Q1 | $3K | Sell |
261
-289
| -53% | -$3.68K | ﹤0.01% | 7432 |
|
|
2021
Q4 | $8K | Buy |
550
+223
| +68% | +$4.72K | ﹤0.01% | 7137 |
|
|
2021
Q3 | $8K | Buy |
327
+92
| +39% | +$2.77K | ﹤0.01% | 7045 |
|
|
2021
Q2 | $8K | Sell |
235
-18
| -7% | -$715 | ﹤0.01% | 6959 |
|
|
2021
Q1 | $12K | Buy |
253
+45
| +22% | +$2.61K | ﹤0.01% | 6736 |
|
|
2020
Q4 | $10K | Buy |
208
+116
| +126% | +$4.36K | ﹤0.01% | 6398 |
|
|
2020
Q3 | $3K | Buy |
92
+5
| +6% | +$282 | ﹤0.01% | 6275 |
|
|
2020
Q2 | $6K | Buy |
+87
| New | +$3.47K | ﹤0.01% | 6011 |
|
|
2019
Q2 | – | Sell |
-66
| Closed | -$1K | – | 7319 |
|
|
2019
Q1 | $1K | Hold |
66
| – | – | ﹤0.01% | 6705 |
|
|
2018
Q4 | $1K | Sell |
66
-31
| -32% | -$543 | ﹤0.01% | 6635 |
|
|
2018
Q3 | $3K | Buy |
97
+24
| +33% | +$913 | ﹤0.01% | 6459 |
|
|
2018
Q2 | $3K | Buy |
73
+6
| +9% | +$297 | ﹤0.01% | 6202 |
|
|
2018
Q1 | $3K | Buy |
67
+1
| +2% | +$50 | ﹤0.01% | 6073 |
|
|
2017
Q4 | $3K | Sell |
66
-52
| -44% | -$2.76K | ﹤0.01% | 6226 |
|
|
2017
Q3 | $7K | Buy |
+118
| New | +$6.91K | ﹤0.01% | 6369 |
|
|
2017
Q2 | – | Sell |
-91
| Closed | -$5.04K | – | 6871 |
|
|
2017
Q1 | $7K | Sell |
91
-16
| -15% | -$1.78K | ﹤0.01% | 6117 |
|
|
2016
Q4 | $16K | Buy |
107
+25
| +30% | +$4.42K | ﹤0.01% | 5888 |
|
|
2016
Q3 | $16K | Buy |
82
+7
| +9% | +$1.29K | ﹤0.01% | 5628 |
|
|
2016
Q2 | $14K | Buy |
+75
| New | +$16.3K | ﹤0.01% | 5642 |
|
Royal Bank of Canada's NH Position: Q2 2023 in Review
Royal Bank of Canada sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 58 shares.
Royal Bank of Canada first reported a position in NH in Q2 2016 and held it in 23 quarters. The position peaked at $16K in Q4 2016. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Royal Bank of Canada reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Royal Bank of Canada sold 58 NantHealth, Inc shares in Q2 2023.
- Royal Bank of Canada first reported a position in NantHealth, Inc in Q2 2016 and held it in 23 quarters.
- Royal Bank of Canada's NantHealth, Inc position peaked at $16K in Q4 2016.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.